P
PLX
Protalix Biother
1.990
-0.020-1.00%After Hours: 1.980 -0.010 -0.50%19:30 06/05 EDT
OPEN/PREV CLOSE1.960/1.960
TODAY RANGE1.960-2.025
VOL460.55K
MARKET CAP159.53M
52 WEEK RANGE1.320-3.190
AVG VOL (3M)827.15K
% TURNOVER0.57%
TURNOVER--
P/E (TTM)10.85
% RANGE3.32%
EPS(TTM)0.1825
P/E(FORWARD)10.15
P/B2.373
BVPS0.8344
DIVIDEND--
P/S3.019
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP153.35M
SHARES OUTSTANDING80.57M
NEXT EARNINGS08/12-08/17
FREE FLOAT77.45M
LOT SIZE1
EX-DATE12/20/2019
News
Press Releases
Financial Reports
Profile
TipRanks·05/21 11:33
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
TipRanks·05/14 00:15
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
Seeking Alpha·05/13 15:52
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Benzinga·05/13 12:19
Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call
Benzinga·05/13 11:11
Earnings Scheduled For May 13, 2026
Seeking Alpha·05/13 10:53
Protalix BioTherapeutics give Q1 results
PR Newswire·05/13 10:50
Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
Seeking Alpha·05/12 22:00
Here are the major earnings before the open Wednesday
Seeking Alpha·05/12 18:07
Protalix BioTherapeutics Q1 Earnings Preview
Seeking Alpha·04/15 18:47
Protalix: Elfabrio Struggles Against Oral Competition
TipRanks·04/02 00:28
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
Seeking Alpha·03/24 18:42
Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.